Rheumatoid Arthritis Clinical Trials in New York

Showing 381-400 of 4,168 trials

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

NCT05664477

This is a proof-of-concept phase 2 clinical trial to investigate the safety and effect of the phytoestrogenic supplement PhytoSERM on regional brain metabolism by fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in peri- and postmenopausal women. The investigators hypothesize that there will be a significant difference between the PhytoSERM group and placebo group in glucose brain metabolism.

MenopauseCognitive ChangeBrain Disorder, Metabolic

Roberta Brinton100 participantsStarted Jan 2024

Tucson, Arizona, United States • New York, New York, United States

Active Not RecruitingPhase 3< 1 mile

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

NCT04901195

The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)

Hidradenitis Suppurativa

UCB Biopharma SRL658 participantsStarted May 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Fountain Valley, California, United States +142 more locations

PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa

Rheumatoid Arthritis Trials in Other Cities

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

A Web-Based Tool to Help People With Health Conditions Make Contraceptive Decisions

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Terumo Aortic Global Endovascular Registry

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

Targeting Aging With a Ketone Ester for Function in Frailty

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

Epcoritamab in Previously Treated WM

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Other Conditions in New York